Ionis Pharmaceuticals, Inc. [NASDAQ: IONS]

Victoria Sanjurjo

Diversity Inclusion Authority

In the dynamic realm of clinical development, where cutting-edge drugs and therapies emerge, there is a glaring issue: the significant underrepresentation of diversity among clinical trial participants. It's akin to hosting a grand fiesta with only a fraction of the invitees in attendance. However, let's transform this landscape! Let's work together to foster a more inclusive and vibrant environment than ever before.

The Usual Suspects: Why Diversity Matters

Picture a clinical trial. If you're imagining a room full of Caucasian males, you're not far off the mark. This homogeneity is more than just dull; it's problematic. It's like testing a one-size-fits-all suit on a single body type and hoping it fits the rest of the world. We need to know how treatments work across all demographics, not just a select few.

A Fresh Perspective: Let’s Shake Things Up

As a member of the clinical development team and a proud first-gen Latina, I've made it my mission to add color and variety to this picture. Even though I have not been able to achieve this for all studies this year, I am hoping to continue to make advances to a more diverse patient population for our clinical studies. Here are some things we can all work on

● Championing Diversity: We can all advocate for diversity and inclusion throughout every phase of clinical trial planning and execution. This encompasses everything from collaborating with colleagues on designing inclusive trial protocols that encourage participation from underrepresented groups to ensure that the entire team aligns with the overarching goal of health equity. It's about integrating diversity into the very fabric of our projects, making it a fundamental aspect of our approach rather than an afterthought.

● Culturally Competent Clinical Teams: From data management and clinical operations to the regulatory team… clinical trial teams should not be just scientifically sharp; they should be culturally tuned in about being as fluent in cultural nuances as they are in scientific data.

● Diverse Doctors for Diverse Trials: Advocacy for more physicians of color in clinical trials goes beyond mere representation; it's fundamentally about fostering relatability and building trust. The solution for those lacking clinical trial experience is clear: provide training and invest in their development. By empowering these doctors with the necessary skills and knowledge, we enhance the trials and strengthen the bonds of trust and understanding with diverse patient populations.

● Clear Consent with No Room for Jargon: Craft consent forms that are readable, relatable, and deeply respectful of cultural nuances. Thinking outside the box is key – for instance, employing video consent presentations has proven effective in enhancing recruitment and retention among people of color. Such innovative methods not only clarify information but also resonate more effectively with diverse groups.

● Data with Depth: Dig deep into the collection and analysis of data based on demographic characteristics to assess any disparities in treatment outcomes.

● Transparent Reporting: Advocate for transparency in reporting clinical trial results, including subgroup analyses that highlight the performance of the treatment in different demographic groups.

I'd be remiss if I didn't address hiring managers in clinical development: the hiring of people of color enriches teams with diverse cultural, social, and personal perspectives, leading to more comprehensive and effective research. Such diversity is instrumental in achieving thorough research and improved healthcare outcomes. Therefore, incorporating inclusive hiring practices is crucial for promoting greater diversity, equity, and inclusivity in our field, ultimately enhancing the quality and impact of our medical research and advancements.

The Impact: Beyond the Lab

This isn't just about ticking boxes. It's about revolutionizing healthcare. By bringing diversity into clinical trials and clinical development, we're making sure studies are designed for everyone and that new treatments aren't just effective for a few but for all. Let us all be a part of breaking down barriers, tackling health disparities, and paving the way for a future where everyone benefits from medical progress.

A Call to Action

Enhancing diversity in clinical trials should not be a side project; it's crucial. It's about making healthcare equitable, effective, and ethical. I'm proud of the strides we're making and excited about the road ahead. When it comes to health, every voice matters, and every participant counts. Let's make clinical trials not just a mirror of a part of society but a true reflection of the vibrant, diverse world we live in.